The different siRNA silencing efficiencies between the ALL cell lines could be explained by differences in endosomal processing pathway or endocytic activities and also different expression levels of STAT5A in the target cells, as reported previously [3, 48, 49]. Here, STAT5A is linked to acute lymphoblastic leukemia.